Ocuphire - OCUP Net earnings per one share for the last twelve months

Public company logo of Ocuphire Corporation (OCUP)

Ocuphire Pharma, Inc. (OCUP) is scaling final tests of its ophthalmological agents while establishing a distribution network in the US. The business relies on patent protection for its presbyopia drops and strict FDA oversight. Stability is provided by high-demand retinal developments in late-stage trials. The percentage change in EPS YoY over 12 months demonstrates profit dynamics, where the value 217.80 represents the current figure.

OCUP Ocuphire: Earnings per share for the last twelve months in the range 02/11/2024 - 02/20/2024

Financial and market metric breakdowns for Ocuphire Corporation (OCUP)

Initial company analysis:Ocuphire Pharma
Manufactured product of Ocuphire

To build a high-quality portfolio, I assess earnings sustainability through EPS TTM YoY dynamics. This metric measures the percentage change in net income per share over a rolling year compared to the same period last year. For Ocuphire Pharma, Inc. (OCUP), this calculation reflects the investment efficiency in developing ophthalmological drugs for vision correction. By analyzing the current EPS TTM YoY growth rate, an investor can determine whether earnings growth results from business scaling or a temporary market spike.

Competitor analysis for Ocuphire Pharma, Inc.

Net earnings per one share for the last twelve months Alcon Inc|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Medical (GKOS)|Earnings per share for the last twelve months apellis.com|Belite Bio (BLTE) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocular Pharma (OCUL)|HROW (Harrow) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) VRDN (Viridian Corp)|LENZ Corp (LENZ) - Net earnings per one share for the last twelve months|OCS: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months eyepointpharma.com|KOD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aldeyra Therapeutics (ALDX)|Net earnings per share for the last 12 months KALA|IRD - Net earnings per share for the trailing year|Earnings per share for the last twelve months okyopharma.com (OKYO)|Net earnings per share (EPS TTM) Adverum Biotechnologies Inc. (ADVM)|Earnings per share for the last twelve months outlooktherapeutics.com OTLK|Net earnings per share for the last four quarters Clearside Biomedical, Inc. (CLSD)|NBY - Earnings per share for the last twelve months|Earnings per share for the trailing year KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Earnings per share for the last twelve months|Eyenovia Inc. - Earnings per share for the trailing year|GHSI (Guardion Health Sciences) - Net earnings per share (EPS TTM)|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters